Avita Medical | 1811094D - Cost Of Sales


Avita Medical reported AUD3.3M in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Accuray USD 116.17M 14.63M Dec/2024
Celltrion KRW 92.83B 14.59B Mar/2026
Clinuvel Pharmaceuticals AUD 2.64M 1.06M Dec/2025
Cochlear AUD 319.2M 160.35M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Divis Laboratories Ltd INR 11.19B 1.2B Jun/2026
Kangmei Pharma CNY 841.45M 271.27M Mar/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Mayne Pharma AUD 43.74M 2.67M Jun/2024
Medical Developments International AUD 7.09M 4.91M Dec/2025
Nanosonics AUD 24.22M 1.11M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organigram Holdings CAD 43.39M 13.54M Mar/2026
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 4.5K 2.62K Dec/2025
Pharma Mar EUR 4.73M 1.08M Jun/2026
Polynovo AUD 9.02M 3.51M Dec/2025
Qiagen NV USD 196.45M 13.73M Jun/2026
Ramsay Health Care AUD 3.05B 78.7M Dec/2025
ResMed USD 540.43M 4.15M Mar/2026
Sartorius EUR 478.7M 5.9M Jun/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
Telix Pharmaceuticals AUD 245.71M 24.35M Jun/2026
Tilray USD 164.37M 8.41M Sep/2025
Zealand Pharma A/S 410K 5K Jun/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026